Turner A, Tsamitros M, Bellomo R, et al. Myocardial cell injuruy in septic shock[J]. Crit Care Med, 1999, 27(3):2035~2036
[2]
Ver Elst KM, Spapen HD, Nguyen DN, et al. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem, 2000, 46(5): 650~657
[3]
Deans K J, Haley M, Natanson C, et al. Novel therapies for sepsis a review[J]. J Trauma, 2005, 58(4): 867~874
[4]
Li J, Zhou H, The pathogenesis of sepsis and its research progress of prevention and control measures[J]. Chongqing Med, 2006,35(16)：1503~1505.(In Chinese)
Angus DC, Linde-Zwirble WT, Lidicker I, et al. Epidemiology of severe sepsis in the United States analysis of incidence outcome and associated costs of care[J]. Crit Care Med, 2001, 29(7): 1303~1310
